Report: A-Rod’s representatives purchased the Biogenesis documents

100 Comments

Admit it: In your heart, you knew it was A-Rod. It’s OK. I thought it might have been too.

Last night the New York Times reported that Major League Baseball’s was attempting to purchase documents from the now-defunct Biogenesis anti-aging clinic.  These documents, as was reported back in January, purport to show that multiple major league ballplayers — as many as 90 by some estimates — obtained banned performance enhancing drugs from Biogenesis and its operator Anthony Bosch.

The documents have formed the basis of a series of eye-opening reports on the matter, but thus far have only been obtained by various media outlets who have chosen not to share them with Major League Baseball. Major League Baseball, of course, would like to see them in order to investigate the reports of PED-using players and, ultimately, discipline said players.  Two weeks ago baseball sued Biogenesis in an effort to get the documents. Now the reports are that Major League Baseball is simply trying to buy them.

According to the New York times, these efforts were spurred by more than a mere desire to get them for baseball’s own sake. Rather, there were rumors that a ballplayer named in the documents was himself trying to purchase them, with an eye toward destroying them and, presumably, head off discipline. Delicious.

Now, Michael S. Schmidt of the New York Times reports who that player is:

The full New York Times report, in which it is alleged that an associate of Alex Rodriguez purchased the documents, can be read here. For his part, Rodriguez’s representatives are flatly denying the report.

If there is an actual basis to this, one wonders if MLB might consider it enough, in and of itself, to consider A-Rod uncooperative with their investigation and thus suspend him summarily pursuant to the Joint Drug Agreement which requires players to cooperate with the league.

At the moment, though, I think MLB would really have to explain why it believes A-Rod was attempting to destroy them. What the basis for that is. Because that’s a pretty serious accusation to hurl without a strong foundation for it.

Either way, however, this story is getting out of control.  If A-Rod did destroy the documents he’s gone super villain on us.  If he did not, and MLB or its surrogates are spinning innuendo, they’ve gone mad instead.

Report: Adam Eaton to miss rest of the season with a torn ACL

Getty Images
2 Comments

It’s been a miserable weekend for Nationals’ outfielder Adam Eaton, who stumbled over first base and injured his leg while running out an infield single in Friday’s 4-3 win over the Mets. While the team officially placed the outfielder on the 10-day disabled list with a left knee strain on Saturday, FOX Sports’ Ken Rosenthal reports that Eaton has been diagnosed with a torn ACL in his left knee and is expected to miss the remainder of the 2017 season. The team has yet to confirm the diagnosis or announce a definite timetable for the 28-year-old’s return, perhaps due to extended evaluations by Eaton’s orthopedic doctor:

The Nationals appear to have several outfield options with Eaton on the disabled list, though they have not pinned down a long-term solution. Center fielder Michael Taylor replaced Eaton on the field during the tail end of Friday’s game, and returned on Saturday to man center and bat second in the lineup. The club also promoted top outfield prospect Rafael Bautista, who slashed .291/.325/.354 with five doubles and a .680 OPS through 19 games in Triple-A Syracuse this season. He’ll assume Eaton’s roster spot and looks to be available for a backup role in the outfield going forward.

Shelby Miller will undergo Tommy John surgery

Getty Images
1 Comment

Last we heard from Shelby Miller, the Diamondbacks’ right-hander was contemplating Tommy John surgery for a partial UCL tear in his right elbow. Now, he appears to have decided to go through with the procedure.

Miller decided to skip Tommy John alternatives like plasma-rich platelet injections or stem cell treatment, which have been used to varying degrees of success by other major league pitchers with similar injuries. The surgery will set him back an estimated 12-18 months, FanRag Sports’ Tommy Stokke reports, which puts Miller’s estimated return date somewhere in 2018 if all goes well.

The 26-year-old starter was off to a rocky start this season, posting a 2-2 record and 4.09 ERA through 22 innings and striking out just 20 of 99 batters faced. This was his sophomore campaign in Arizona after muddling through the 2016 season with a 3-12 record, 6.15 ERA and 0.5 fWAR over 101 innings with the club.